Chairman changes chair
29.01.2013 - Instead of renewing his contract, Bayer Healthcare AG Chairman Jörg Reinhardt (56) is seeking new opportunities.
The member of Bayer‘s Executive Council is standing for election as Director and non-executive Chairman at Novartis, and hopes to follow Daniel Vasella in the post. Board member Wolfgang Plischke will take over Reinhardt's role at Bayer. The pharma executive is returning to his roots. He began his career with Sandoz in 1981, which became part of Novartis 15 years later. In 2008, Reinhardt became COO of the Novartis Group, and in 2012 he was appointed to the Board of Lonza Group AG in Basel.
Photo: Bayer HealthCarehttp://www.european-biotechnology-news.com/people/bio-people/2013-01/joerg-reinhardt.html